| Name | Title | Contact Details |
|---|
Northfield Hospital & Clinics is an independent, integrated health care organization providing a wide range of healthcare services to patients throughout the southern metro region. Northfield Hospital & Clinics’ regional approach is designed to extend primary care services throughout the area and provide the patient base necessary to develop important specialty practices, such as cardiology and oncology, and make them more accessible to area residents. Our individual clinics include the primary and specialty care FamilyHealth Clinics located in Lonsdale, Northfield, Farmington, Elko New Market and Lakeville. The Northfield Hospital & Clinics network also features specialty clinics, including Women’s Health Center, Orthopaedic & Fracture Clinic, and Northfield Eye Physicians & Surgeons. Become an exceptional healthcare system and the provider of choice in the region.Northfield Hospital & Clinics provides a wide spectrum of medical services to residents of Rice, Dakota, Scott and Goodhue counties. Combining advanced technology with personalized, patient-centered care, we strive to create a healing environment where patients feel safe, secure and supported.
Rice Medical Center is a Eagle Lake, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Monte Nido & Affiliates is a company that provides eating disorder treatment in a serene, natural environment, where clinicians provide state of the art care for mind, body and soul.
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.